Direct-acting antiviral treatment for HCV.
Goutzamanis S, Doyle J, Thompson A, Hellard M, Higgs P
Hepatitis C
Field engagement further facilitates hepatitis B vaccination completion: Letter in response to: Day et al. (in press).
Higgs P, Doyle J, Luppi J, Dietze P, Hellard M
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME, ATAHC Study Group
Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.
Hellard M, Sacks-Davis R, Doyle J
A systematic review of community based hepatitis C treatment.
Wade AJ, Veronese V, Hellard ME, Doyle JS
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.
Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME